COVID-19-Associated Invasive Pulmonary Aspergillosis in the Intensive Care Unit: A Case Series in a Portuguese Hospital

被引:6
作者
Ranhel, David [1 ]
Ribeiro, Ana [1 ]
Batista, Judite [1 ]
Pessanha, Maria [1 ]
Cristovam, Elisabete [1 ]
Duarte, Ana [1 ]
Dias, Ana [1 ]
Coelho, Luis [1 ]
Monteiro, Filipa [1 ]
Freire, Pedro [1 ]
Verissimo, Cristina [2 ]
Sabino, Raquel [2 ,3 ]
Toscano, Cristina [1 ]
机构
[1] Ctr Hosp Lisboa Ocidental, P-1349019 Lisbon, Portugal
[2] Natl Hlth Inst Dr Ricardo Jorge, Infect Dis Dept, P-1649016 Lisbon, Portugal
[3] Univ Lisbon, Fac Med, Inst Saude Ambiental, P-1649028 Lisbon, Portugal
关键词
COVID-19; intensive care unit; Aspergillus; invasive pulmonary aspergillosis; COVID-19-associated invasive pulmonary aspergillosis; COVID-19;
D O I
10.3390/jof7100881
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Invasive pulmonary aspergillosis (IPA) has become a recognizable complication in coronavirus disease 2019 (COVID-19) patients admitted to intensive care units (ICUs). Alveolar damage in the context of acute respiratory distress syndrome (ARDS) appears to be the culprit in facilitating fungal invasion in COVID-19 patients, leading to a COVID-19-associated pulmonary aspergillosis (CAPA) phenomenon. From November 2020 to 15 February 2021, 248 COVID-19 patients were admitted to our ICUs, of whom ten patients (4% incidence) were classified as either probable (six) or possible (four) CAPA cases. Seven patients had positive cultural results: Aspergillus fumigatus sensu stricto (five), A. terreus sensu stricto (one), and A. welwitschiae (one). Five patients had positive bronchoalveolar lavage (BAL) and galactomannan (GM), and two patients had both positive cultural and GM criteria. All but two patients received voriconazole. Mortality rate was 30%. Strict interpretation of classic IPA definition would have resulted in eight overlooked CAPA cases. Broader diagnostic criteria are essential in this context, even though differentiation between Aspergillus colonization and invasive disease might be more challenging. Herein, we aim to raise awareness of CAPA in view of its potential detrimental outcome, emphasizing the relevance of a low threshold for screening and early antifungal treatment in ARDS patients.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital
    Elisabeth Paramythiotou
    George Dimopoulos
    Nikolaos Koliakos
    Maria Siopi
    Sophia Vourli
    Spyros Pournaras
    Joseph Meletiadis
    Infectious Diseases and Therapy, 2021, 10 : 1779 - 1792
  • [32] Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital
    Paramythiotou, Elisabeth
    Dimopoulos, George
    Koliakos, Nikolaos
    Siopi, Maria
    Vourli, Sophia
    Pournaras, Spyros
    Meletiadis, Joseph
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (03) : 1779 - 1792
  • [33] Navigating Uncertainty: Managing Influenza-Associated Invasive Pulmonary Aspergillosis in an Intensive Care Unit
    Casalini, Giacomo
    Giacomelli, Andrea
    Galimberti, Laura
    Colombo, Riccardo
    Milazzo, Laura
    Cattaneo, Dario
    Castelli, Antonio
    Antinori, Spinello
    JOURNAL OF FUNGI, 2024, 10 (09)
  • [34] Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis
    Lamoth, Frederic
    Lewis, Russell E.
    Walsh, Thomas J.
    Kontoyiannis, Dimitrios P.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (10) : 1631 - 1640
  • [35] New insights into development and mortality of COVID-19-associated pulmonary aspergillosis in a homogenous cohort of 1161 intensive care patients
    Hashim, Zia
    Nath, Alok
    Khan, Ajmal
    Neyaz, Zafar
    Marak, Rungmei S. K.
    Areekkara, Prasant
    Tiwari, Atul
    Srivastava, Shivani
    Agarwal, Vikas
    Saxena, Swati
    Tripathy, Nidhi
    Azim, Afzal
    Gupta, Mansi
    Mishra, Durga Prasanna
    Mishra, Prabhakar
    Singh, Ratender Kumar
    Gupta, Devender
    Gupta, Anshul
    Sanjeev, Om Prakash
    Ghatak, Tanmoy
    Ghoshal, Ujjala
    Dhiman, Radha Krishan
    Tripathy, Naresh Kumar
    MYCOSES, 2022, 65 (11) : 1010 - 1023
  • [36] Mortality in ICU Patients with COVID-19-Associated Pulmonary Aspergillosis
    Beltrame, Anna
    Stevens, David A.
    Haiduven, Donna
    JOURNAL OF FUNGI, 2023, 9 (06)
  • [37] Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis
    Fischer, Tim
    El Baz, Yassir
    Graf, Nicole
    Wildermuth, Simon
    Leschka, Sebastian
    Kleger, Gian-Reto
    Pietsch, Urs
    Frischknecht, Manuel
    Scanferla, Giulia
    Strahm, Carol
    Walti, Stephan
    Dietrich, Tobias Johannes
    Albrich, Werner C.
    DIAGNOSTICS, 2022, 12 (05)
  • [38] COVID-19-associated pulmonary aspergillosis in a tertiary care center in the Midwestern Region of Brazil
    Ely, Marina Miranda
    Tetila, Andyane Freitas
    Paniago, Anamaria Mello Miranda
    Rossato, Luana
    MEDICAL MYCOLOGY, 2025, 63 (03)
  • [39] Two cases of COVID-19-associated pulmonary aspergillosis (CAPA)
    Lim, Jin Lee
    Khor, Inn Shih
    Moh, Cheng Keat
    Chan, Yi Min
    Lam, Yoke Fong
    Lachmanan, Kumaresh Raj
    RESPIROLOGY CASE REPORTS, 2022, 10 (04):
  • [40] Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients
    Feys, Simon
    Carvalho, Agostinho
    Clancy, Cornelius J.
    Gangneux, Jean-Pierre
    Hoenigl, Martin
    Lagrou, Katrien
    Rijnders, Bart J. A.
    Seldeslachts, Laura
    Vanderbeke, Lore
    van de Veerdonk, Frank L.
    Verweij, Paul E.
    Wauters, Joost
    LANCET RESPIRATORY MEDICINE, 2024, 12 (09) : 728 - 742